Acute pyelonephritis in cats is frequently caused by Escherichia coli resistant to potentiated penicillins but has a better prognosis than other causes of acute kidney injury

J Am Vet Med Assoc. 2023 Nov 16;262(2):232-240. doi: 10.2460/javma.23.08.0488. Print 2024 Feb 1.

Abstract

Objective: To describe the clinical findings, microbiological data, treatment, and outcome of a population of cats with suspected acute pyelonephritis (APN).

Animals: 32 client-owned cats.

Clinical presentation and procedures: Retrospective case series from 2 veterinary teaching hospitals between January 1, 2014, and December 31, 2020. Cats were included if they had a positive bacterial urine culture and a clinical diagnosis of acute kidney injury.

Results: Older female cats with underlying chronic kidney disease have a higher probability to develop bacterial culture-positive acute kidney injury or APN. Escherichia coli was the most commonly cultured bacterial species, and E coli isolates with susceptibility testing were resistant to amoxicillin-clavulanate but susceptible to fluoroquinolones or third-generation cephalosporins. Of the 20 cats with available follow-up information in the medical record, 14 were alive at 3 months after hospital discharge. Markers of renal function including creatinine (P = .008), BUN (P = .005), and phosphorus (P < .001) at the time of presentation were all higher in nonsurvivors compared with survivors.

Clinical relevance: The survival rate with feline APN is higher than previous reports of acute kidney injury when all etiologies are considered. Nonsurvivors had more pronounced azotemia upon initial presentation. Amoxicillin-clavulanate was a poor empirical antimicrobial in this cohort based on the microbiological data.

Keywords: acute kidney injury; bacteriuria; feline; pyelonephritis; urine culture.

MeSH terms

  • Acute Kidney Injury* / veterinary
  • Amoxicillin-Potassium Clavulanate Combination / therapeutic use
  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Cat Diseases* / drug therapy
  • Cats
  • Escherichia coli
  • Escherichia coli Infections* / complications
  • Escherichia coli Infections* / drug therapy
  • Escherichia coli Infections* / veterinary
  • Female
  • Humans
  • Penicillins / therapeutic use
  • Prognosis
  • Pyelonephritis* / drug therapy
  • Pyelonephritis* / epidemiology
  • Pyelonephritis* / veterinary
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents
  • Penicillins
  • Amoxicillin-Potassium Clavulanate Combination